Stoppel Whitney L, Ghezzi Chiara E, McNamara Stephanie L, Black Lauren D, Kaplan David L
Department of Biomedical Engineering, Tufts University, Medford, MA, 02155, USA.
Ann Biomed Eng. 2015 Mar;43(3):657-80. doi: 10.1007/s10439-014-1206-2. Epub 2014 Dec 24.
Naturally derived polymeric biomaterials, such as collagens, silks, elastins, alginates, and fibrins are utilized in tissue engineering due to their biocompatibility, bioactivity, and tunable mechanical and degradation kinetics. The use of these natural biopolymers in biomedical applications is advantageous because they do not release cytotoxic degradation products, are often processed using environmentally-friendly aqueous-based methods, and their degradation rates within biological systems can be manipulated by modifying the starting formulation or processing conditions. For these reasons, many recent in vivo investigations and FDA-approval of new biomaterials for clinical use have utilized natural biopolymers as matrices for cell delivery and as scaffolds for cell-free support of native tissues. This review highlights biopolymer-based scaffolds used in clinical applications for the regeneration and repair of native tissues, with a focus on bone, skeletal muscle, peripheral nerve, cardiac muscle, and cornea substitutes.
天然衍生的聚合物生物材料,如胶原蛋白、丝绸、弹性蛋白、藻酸盐和纤维蛋白,因其生物相容性、生物活性以及可调节的力学和降解动力学而被用于组织工程。这些天然生物聚合物在生物医学应用中的使用具有优势,因为它们不会释放细胞毒性降解产物,通常采用环保的水基方法进行加工,并且它们在生物系统中的降解速率可以通过改变起始配方或加工条件来控制。由于这些原因,最近许多体内研究以及用于临床的新生物材料的FDA批准都利用天然生物聚合物作为细胞递送的基质和用于天然组织无细胞支持的支架。本综述重点介绍了用于临床应用中天然组织再生和修复的基于生物聚合物的支架,重点关注骨、骨骼肌、周围神经、心肌和角膜替代物。